Antibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 27484-1-AP - Provider product page

- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#27484-1-AP, RRID:AB_2810294
- Product name
- MRPL4 antibody
- Antibody type
- Polyclonal
- Description
- MRPL4 antibody (Cat. #27484-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: IF, IHC, WB, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Cancer-Associated Fibroblast-Derived Sphingosine-1-Phosphate Activates a MALL-SDC4 Axis to Facilitate Perineural Invasion in Pancreatic Cancer.
DDX49 as a novel prognostic biomarker regulates colorectal cancer cell proliferation through the TIMM44-PI3K-AKT pathway.
Construction of molecular subtype and prognostic model for gastric cancer based on nucleus-encoded mitochondrial genes.
A roadmap for ribosome assembly in human mitochondria.
Tetracycline-dependent inhibition of mitoribosome protein elongation in mitochondrial disease mutant cells suppresses IRE1α to promote cell survival.
CoLoC-seq probes the global topology of organelle transcriptomes.
Tetracyclines activate mitoribosome quality control and reduce ER stress to promote cell survival.
Tetracyclines promote survival and fitness in mitochondrial disease models.
Peng W, Cao M, Huang H, Bai S, Liu L, Liang J, Cui H, Zhou Q, Chen S, Jiang J, Liu L, Luan Z, Chen W, Xiong S, Wang R, Cheng B, Zhao Y
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Apr 22;:e75426
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026 Apr 22;:e75426
DDX49 as a novel prognostic biomarker regulates colorectal cancer cell proliferation through the TIMM44-PI3K-AKT pathway.
Huang B, Yin Z, Gao G, Li L, Yang M
Frontiers in oncology 2025;15:1707092
Frontiers in oncology 2025;15:1707092
Construction of molecular subtype and prognostic model for gastric cancer based on nucleus-encoded mitochondrial genes.
Wang X, Li S, Shen Y, Cao L, Lu Y, Cao J, Liu Y, Deng A, Yang J, Wang T
Scientific reports 2024 Nov 18;14(1):28491
Scientific reports 2024 Nov 18;14(1):28491
A roadmap for ribosome assembly in human mitochondria.
Lavdovskaia E, Hanitsch E, Linden A, Pašen M, Challa V, Horokhovskyi Y, Roetschke HP, Nadler F, Welp L, Steube E, Heinrichs M, Mai MM, Urlaub H, Liepe J, Richter-Dennerlein R
Nature structural & molecular biology 2024 Dec;31(12):1898-1908
Nature structural & molecular biology 2024 Dec;31(12):1898-1908
Tetracycline-dependent inhibition of mitoribosome protein elongation in mitochondrial disease mutant cells suppresses IRE1α to promote cell survival.
Ronayne CT, Bennett CF, Perry EA, Kantorovich N, Puigserver P
bioRxiv : the preprint server for biology 2023 Mar 21;
bioRxiv : the preprint server for biology 2023 Mar 21;
CoLoC-seq probes the global topology of organelle transcriptomes.
Jeandard D, Smirnova A, Fasemore AM, Coudray L, Entelis N, Förstner KU, Tarassov I, Smirnov A
Nucleic acids research 2023 Feb 22;51(3):e16
Nucleic acids research 2023 Feb 22;51(3):e16
Tetracyclines activate mitoribosome quality control and reduce ER stress to promote cell survival.
Ronayne CT, Jackson TD, Bennett CF, Perry EA, Kantorovic N, Puigserver P
EMBO reports 2023 Dec 6;24(12):e57228
EMBO reports 2023 Dec 6;24(12):e57228
Tetracyclines promote survival and fitness in mitochondrial disease models.
Perry EA, Bennett CF, Luo C, Balsa E, Jedrychowski M, O'Malley KE, Latorre-Muro P, Ladley RP, Reda K, Wright PM, Gygi SP, Myers AG, Puigserver P
Nature metabolism 2021 Jan;3(1):33-42
Nature metabolism 2021 Jan;3(1):33-42
No comments: Submit comment
No validations: Submit validation data